+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
3SBio Inc - logo

3sbio is a biotechnology company that creates biopharmaceutical products. The company was incorporated in 2006, and is headquartered in Shenyang, China. It is a subsidiary of Decade Sunshine Limited. Their products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; and EPIAO, an injectable recombinant human erythropoietin for anemia associated with chronic kidney disease (CKD) and chemotherapy, as well as to reduce allogeneic blood transfusion in surgery patients. 3sbio sell their products to a range of countries including: Brazil, Colombia, Costa Rica ,Dominican Republic, Egypt, El Salvador, Guatemala, Laos, Mongolia, Myanmar, Pakistan, Paraguay, Philippines, Sri Lanka, Thailand and Trinidad and Tobago.

From
From
From
From
Erythropoietin (EPO) Global Market Report 2024 - Product Thumbnail Image

Erythropoietin (EPO) Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Type 2 Diabetes - Pipeline Review, H2 2020 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1251 Pages
  • Global
From
Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2020 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 684 Pages
  • Global
From
Regenerative Medicine for Cartilage Global Market Report 2024 - Product Thumbnail Image

Regenerative Medicine for Cartilage Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Biologics Global Market Report 2024 - Product Thumbnail Image

Biologics Global Market Report 2024

  • Report
  • February 2024
  • 400 Pages
  • Global
From
End-Stage Renal Disease - Pipeline Insight, 2024 - Product Thumbnail Image

End-Stage Renal Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Diabetic Retinopathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Retinopathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 358 Pages
  • Global
From
From
From
From
Hyperphosphatemia - Pipeline Review, H1 2020 - Product Thumbnail Image

Hyperphosphatemia - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 80 Pages
  • Global
From
Loading Indicator